Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02106650 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies
A Phase 2 study, sponsored by Acrotech Biopharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT02106650 is a Phase 2 study that has completed, run by Acrotech Biopharma. The registered enrollment target is 36 participants.
The verdict
NCT02106650, a Phase 2 study, has completed, sponsored by Acrotech Biopharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study is to evaluate the effect of leucovorin in preventing or reducing Folotyn-related Grade 2 or higher oral mucositis.
Interventions
- DRUG Folic Acid
- DRUG Vitamin B12
- DRUG Folotyn and Leucovorin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-07 |
| Est. Completion | 2019-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02106650
The ClinicalTrials.gov registry entry for NCT02106650 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Acrotech Biopharma, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Folic Acid is the first listed.
NCT02106650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02106650 about?
NCT02106650 is a clinical study titled "Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies". This study is to evaluate the effect of leucovorin in preventing or reducing Folotyn-related Grade 2 or higher oral mucositis.
What is the current status of trial NCT02106650?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2014-07. Estimated completion is 2019-06.
What interventions are being tested in trial NCT02106650?
The interventions under investigation include: Folic Acid (DRUG), Vitamin B12 (DRUG), Folotyn and Leucovorin (DRUG).
Who is sponsoring clinical trial NCT02106650?
This trial is sponsored by Acrotech Biopharma, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.